REFERENCES
- Moncada S. Nitric oxide. J Hypertension 1994; 12: 535–537
- Yanagisawa M, Kurihara M H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 323: 411–415
- Panza J A, Quyyumi A A, Brush J E, Epstein S E. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Eng J Med 1988; 323: 22–27
- William G, Noon J P, Brian R W, Webb D J. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertension 1993; 11: 375–380
- Hirooka Y, Imazume T, Masaki H, et al. Captopril improves impaired endothelium dependent vasodilatation in hypertensive patients. Hypertension 1992; 20: 175–180
- Clozel M, Kuhn M, Hefti F. Effects of angiotensin converting enzyme inhibition and hydralazine as endothelial function in hypertensive rats. Hypertension 1990; 16: 537–540
- Berkenboom, Brekine D, Lenger P, Grosfils K, Staroukine M, Fontaine J. Chronic angiotensin converting enzyme inhibition and endothelial function of rat aorta. Hypertension 1995; 26: 738–743
- Cachofeiro N, Maeso R, Rodrigo E, Navorro J, Ruilope L, Lahera V. Nitric oxide and prostaglandin in the prolonged effects of Losartan And Rampiril in hypertension. Hypertension 1995; 26: 236–243
- Erlich Y, Rosenthal T. Contribution of NO to the beneficial effects of enalapril in the fructose induced hyperinsulinemic rat. Hypertension 1996; 28: 754–757
- Zanzinger J, Zheng X, Barsenger E. Endothelium dependent vaomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism. Cardiovasc Res 1994; 28: 209–214
- Green L C, Wagner D A, Glaghowski J, et al. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal Biochem 1982; 126: 131–38
- Boyde T RC, Rahmatullah M. Optimization of conditions for the colorimetric determination of citrulline using diacetyl monoxime. Annal Biochem 1980; 107: 424–431
- Rees D D, Palmer R MJ, Hudson H F, Moncada S. A specific inhibitor of NO formation from L-arginine attenuates endothelium dependent relaxation. Br J Pharmacol 1989; 96: 418–424
- Calver A, Collier J, Moncada S, Vallance P. Effect of local intraarterial NG-monomethyl C-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertension 1992; 10: 1025–1031
- Kumar V K, Das U N. Are free radicals involved in the pathobiology of human essential hypertrension?. Free radial Comms 1993; 19: 59–66
- Gardner S M, Bennett T. Involvement of nitric oxide in the regional hemodynamic effects of perindoprilat and captopril in hypovolemic Balttabroo rats. Br J Pharmacol 1992; 107: 1181–1191
- Kiowski W, Linder L, Kleinblossem C, Brummeles P V, Buhler F R. Blood pressure control by the renin angiotensin system in normotensive subjects-Assessment by angiotensin converting enzyme and renin inhibition. Circulation 1992; 85: 1–8
- Goonasekera C DA, Shah V, Rees D D, Dillon M J. Nitric oxide activity in childhood hypertension. Arch Dis Child 1997; 77: 11–16
- Takahashi H, Nakanishi J, Nishimura M, Tanaka H, Yoshimura M. Measurements of serum levels of nitrite ions in men and women, Implications of endothelium derived relaxing factors in blood pressure regulation and atherosclerosis. J Cardiovasc Pharmacol 1992; 20(Suppl. 12)S214–216
- Forte P, Copland M, Smith L M, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349: 837–842
- Hecker M, Sessa W C, Harris H J, Anggard E E, Vane J R. The metabolism of L-arginine and its significance for the biosynthesis of endothelium derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci USA 1990; 80: 8612–8616